Literature DB >> 19917822

Long-term mortality and vascular event risk after aneurysmal subarachnoid haemorrhage.

M J H Wermer1, P Greebe, A Algra, G J E Rinkel.   

Abstract

BACKGROUND: Patients with a history of subarachnoid haemorrhage (SAH) may be at risk for vascular events and excess mortality.
METHODS: We interviewed 752 patients (mean age 50 years, 67% women, mean follow-up 8.1 years) clipped between 1985 and 2001 after SAH who had been discharged home or to a rehabilitation facility about new vascular events. We compared age- and sex-specific mortality after SAH with that of the general population by standardised mortality ratios (SMR). The incidence of vascular events in SAH patients was compared with that in patients after a transient ischaemic attack or minor stroke.
RESULTS: The SMR for SAH patients was 1.7 (95% CI 1.4 to 2.1) overall and 3.2 (95% CI 0.8 to 13.1) for patients <40 years. In the first 10 years after SAH the cumulative incidence of a vascular event was 11.2% (95% CI 7.0 to 14.4), which was lower (hazard ratio 0.43, 95% CI 0.33 to 0.57) than that in patients with a minor stroke.
CONCLUSION: SAH patients who recover to a functional independent state have an excess mortality compared with the general population. The risk of vascular events after SAH is lower than after minor stroke, but higher than the population risks reported in the literature.

Entities:  

Mesh:

Year:  2009        PMID: 19917822     DOI: 10.1136/jnnp.2008.157586

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage.

Authors:  Miikka Korja; Karri Silventoinen; Tiina Laatikainen; Pekka Jousilahti; Veikko Salomaa; Jaakko Kaprio
Journal:  Neurology       Date:  2013-01-09       Impact factor: 9.910

2.  Long-term outcome after aneurysmal subarachnoid hemorrhage-risks of vascular events, death from cancer and all-cause death.

Authors:  Dennis J Nieuwkamp; Arno de Wilde; Marieke J H Wermer; Ale Algra; Gabriël J E Rinkel
Journal:  J Neurol       Date:  2013-11-26       Impact factor: 4.849

3.  Argon treatment after experimental subarachnoid hemorrhage: evaluation of microglial activation and neuronal survival as a subanalysis of a randomized controlled animal trial.

Authors:  Benedikt Kremer; Mark Coburn; Agnieszka Weinandy; Kay Nolte; Hans Clusmann; Michael Veldeman; Anke Höllig
Journal:  Med Gas Res       Date:  2020 Jul-Sep

4.  Clinical characteristics and factors relating to poor outcome in patients with aneurysmal subarachnoid hemorrhage in Vietnam: A multicenter prospective cohort study.

Authors:  Chinh Quoc Luong; Hung Manh Ngo; Hai Bui Hoang; Dung Thi Pham; Tuan Anh Nguyen; Tuan Anh Tran; Duong Ngoc Nguyen; Son Ngoc Do; My Ha Nguyen; Hung Dinh Vu; Hien Thi Thu Vuong; Ton Duy Mai; Anh Quang Nguyen; Kien Hoang Le; Phuong Viet Dao; Thong Huu Tran; Luu Dang Vu; Linh Quoc Nguyen; Trang Quynh Pham; He Van Dong; Hao The Nguyen; Chi Van Nguyen; Anh Dat Nguyen
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

5.  Short- and long-term outcome of patients with aneurysmal subarachnoid hemorrhage.

Authors:  Jaume Roquer; Elisa Cuadrado-Godia; Leopoldo Guimaraens; Gerardo Conesa; Ana Rodríguez-Campello; Jaume Capellades; María P García-Arnillas; Juan L Fernández-Candil; Carla Avellaneda-Gómez; Eva Giralt-Steinhauer; Jordi Jiménez-Conde; Carolina Soriano-Tárraga; Gloria Villalba-Martínez; Rosa M Vivanco-Hidalgo; Elio Vivas; Angel Ois
Journal:  Neurology       Date:  2020-08-13       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.